The Dallas Cowboys began Organized Team Activities this week and received some unfavorable news. Dallas-area beat writer and radio personality Mike Fisher of 105.3 The Fan reported that third-year free agent defensive end David Irving is facing a four-game suspension for violating the NFL’s performance enhancing drug policy.
Dallas Cowboys David Irving Facing Suspension
Reportedly, Irving received a deal to endorse a supplement that contained a substance outlawed by the league. Irving is determined to appeal the pending suspension. The potential fallout can be viewed two ways.
Growth Stopped
First, it could be a huge setback for Irving who had begun to come on strong in 2016. The 6’7” 273 pound 23-year-old finished the season with four sacks, five passes defensed and four forced fumbles. His development could be cut short with the time missed.
Opportunity Knocks
Secondly, the suspension will give several young players a chance to earn significant playing time early in the season. Players like Taco Charlton and Charles Tapper will get plenty of opportunities with Irving missing from defensive coordinator Rod Marinelli’s cupboard.
Benson Mayowa and the newly acquired Damontre Moore could also benefit from Irving’s absence. Ultimately, Irving was not likely to earn a starting role with this year’s team but his availability was considered a decided edge.
The team hopes he’s able to win his appeal and miss a minimal number of games but they will not hold their breath. The Cowboys have an abundance of young talent that will allow them to remain competitive along the defensive front. The team’s biggest concern will be keeping everyone else healthy, if he is suspended.
